TY - JOUR
T1 - Multiple myeloma and its rare paraneoplastic manifestations simmering under the surface
AU - Baloch, Sehrish Sarwar
AU - Khan, Saqib Raza
AU - Tariq, Muhammad
AU - Wasio, Abdul
AU - Ali, Ayesha Arshad
AU - Shahzadi, Mehwish
AU - Moosajee, Munira
AU - Anwar, Shaheena
AU - Raza, Afsheen
AU - Uddin, Shahab
N1 - Publisher Copyright:
© 2023 Elsevier GmbH
PY - 2023/8
Y1 - 2023/8
N2 - Paraneoplastic syndromes are complex clinical manifestations that occur because of the underlying malignancy in which the malignant cells produce hormones, cytokines, peptides or antibodies that causes symptoms and may affect multiple organ systems. These paraneoplastic conditions may be associated with different solid and hematological malignancies. Multiple Myeloma (MM) accounts for 10–15 % of hematological malignancies and 1–2 % of all malignancies. It is associated with some atypical clinical and laboratory paraneoplastic manifestations. Although there is a low incidence of these paraneoplastic, significant knowledge of these manifestations may assist in making a differential diagnosis in cases of doubt. The clinical presentation may vary and be evident even before or after the diagnosis of malignancy. These include vascular, neurological, dermatological, physiological, and other atypical conditions. Furthermore, these rare paraneoplastic manifestations need more valid, relevant scientific information, as most information about these conditions is derived from case reports. After the literature search, we have reported the paraneoplastic manifestations associated with multiple myeloma, published in the English literature, and the cognate management in this review article. To our knowledge, this is the first review article discussing various paraneoplastic manifestations of multiple myeloma.
AB - Paraneoplastic syndromes are complex clinical manifestations that occur because of the underlying malignancy in which the malignant cells produce hormones, cytokines, peptides or antibodies that causes symptoms and may affect multiple organ systems. These paraneoplastic conditions may be associated with different solid and hematological malignancies. Multiple Myeloma (MM) accounts for 10–15 % of hematological malignancies and 1–2 % of all malignancies. It is associated with some atypical clinical and laboratory paraneoplastic manifestations. Although there is a low incidence of these paraneoplastic, significant knowledge of these manifestations may assist in making a differential diagnosis in cases of doubt. The clinical presentation may vary and be evident even before or after the diagnosis of malignancy. These include vascular, neurological, dermatological, physiological, and other atypical conditions. Furthermore, these rare paraneoplastic manifestations need more valid, relevant scientific information, as most information about these conditions is derived from case reports. After the literature search, we have reported the paraneoplastic manifestations associated with multiple myeloma, published in the English literature, and the cognate management in this review article. To our knowledge, this is the first review article discussing various paraneoplastic manifestations of multiple myeloma.
KW - Case reports
KW - Multiple myeloma
KW - Paraneoplastic symptoms
KW - Polycythemia vera
KW - Sweet syndrome
UR - http://www.scopus.com/inward/record.url?scp=85165208315&partnerID=8YFLogxK
U2 - 10.1016/j.prp.2023.154689
DO - 10.1016/j.prp.2023.154689
M3 - Review article
C2 - 37478520
AN - SCOPUS:85165208315
SN - 0344-0338
VL - 248
JO - Pathology Research and Practice
JF - Pathology Research and Practice
M1 - 154689
ER -